This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ConfometRx Research Foundation Announces 2013 GPCR Workshop

PALO ALTO, Calif., March 27, 2013 /PRNewswire-USNewswire/ -- ConfometRx Research Foundation is pleased to announce the 2013 GPCR Workshop to be held at Hyatt Regency, Maui Dec 1-5, 2013.  The Royal Swedish Academy of Sciences called global attention to the significance of G protein coupled receptors (GPCRs) by awarding the 2012 Nobel Prize in Chemistry to two pioneers in the field.  GPCRs mediate the senses of sight, olfaction and taste, as well as the physiologic responses to the majority of hormones and neurotransmitters in the human body. As such GPCRs are the targets for nearly 50% of all marketed drugs, and are potential targets for many unmet medical needs. 

The goals of the workshop are to bring together scientists from academia and the pharmaceutical and biotechnology industries to discuss the most challenging problems in the GPCR field and explore new ways to work together to find solutions. The workshop will encourage mutual sharing of ongoing research results, both successes and failures, so as to facilitate progress in the development of more effective therapeutics for G protein coupled receptor targets.

The format for this workshop will encourage a free flow of ideas centered around key problems facing GPCR drug discovery, and a discussion of what different investigators have tried, what has worked, and what has failed. Morning sessions will consist of presentations from invited speakers covering a range of topics. Evening interactive sessions will provide a forum for attendees to present and discuss their latest research. The conference will follow the principles of the Gordon Research Conferences, where the participants will hold data and ideas discussed at the workshop in confidence.

The co-organizers of the workshop include the founders of the ConfometRx Research Foundation, Tong Sun and Brian Kobilka, who are also co-founders of ConfometRx, a sponsor of the workshop, and Arthur Christopoulos and Patrick Sexton of Monash Institute of Pharmaceutical Sciences, Melbourne, Australia, also a workshop sponsor.  The environment of the workshop is informal and dynamic, and conducive to a free flow of ideas.  We encourage the participation of pharmaceutical companies through sponsorship and participation in the workshop.  Please visit the website for information and registration: www.gpcrworkshop.com.

SOURCE ConfometRx

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs